Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on November 1, 2003

Published online before print July 15, 2003
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0403171v1
74/5/702    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chougnet, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chougnet, C.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0403171

Received for publication April 22, 2003.
Revised June 10, 2003.
Accepted for publication June 17, 2003.

Article

Role of CD40 Ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells

Claire Chougnet @

Cincinnati Children's Hospital Research Foundation, Cincinnati, OH

@ To whom correspondence should be addressed. E-mail: claire.chougnet{at}chmcc.org.


  Abstract

Cellular interactions between antigen-presenting cells and activated CD4+ T cells are central to the regulation of adaptive immunity. Among the many receptor-ligand pairs involved, the critical importance of CD40-CD40 Ligand (CD40L) interactions has been demonstrated in many experimental systems. Dysregulation of antigen-presenting cell function is a hallmark of HIV-associated defects in cell-mediated immunity. Much evidence suggests a mechanistic role for defective CD40-CD40L interactions in such a defect. Consistent with this hypothesis, the capacity to upregulate CD40L on purified CD4+ T cells becomes progressively impaired in HIV infection, in parallel with the progression of clinical immunosuppression. The mechanisms underlying CD40L dysregulation in HIV infection remain unknown. Because CD40L expression is tightly regulated (transcriptionally, post-transcriptionally and post-translationally), HIV may interfere at several levels. However, a transcriptional defect in CD40L expression, mediated by the engagement of CD4 by HIV gp120, appears to play a primary role. Clear elucidation of mechanism may well lead to the development of novel immunotherapeutic approaches to HIV infection.

Key Words: gp120 • interleukin-12 • immune suppression • CD4




This article has been cited by other articles:


Home page
 BloodHome page
R. Zhang, J. D. Lifson, and C. Chougnet
Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions
Blood, March 1, 2006; 107(5): 1989 - 1995.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
V. L. Hodara, M. C. Velasquillo, L. M. Parodi, and L. D. Giavedoni
Expression of CD154 by a Simian Immunodeficiency Virus Vector Induces Only Transitory Changes in Rhesus Macaques
J. Virol., April 15, 2005; 79(8): 4679 - 4690.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
R. G. Collman, C.-F. Perno, S. M. Crowe, M. Stevenson, and L. J. Montaner
HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions
J. Leukoc. Biol., November 1, 2003; 74(5): 631 - 634.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2003 by the Society for Leukocyte Biology.